FTO and nonpapillary renal cell carcinoma: FTO downregulation is also associated with poor survival of patients with ccRCC and upregulates the expression of a central regulator of mitochondrial function, namely PPARδ coactivators‐1α (PGC‐1α), to induce oxidative stress and suppress ccRCC growth.425